Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

CD2_BENIGN_EAR_NASAL_SINUS

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D14.0& Hospital discharge: ICD-9 — 2120 Hospital discharge: ICD-8 — 2120 Cause of death: ICD-10 — D14.0& Cause of death: ICD-9 — 2120 Cause of death: ICD-8 — 2120 2 out of 7 registries used, show all original rules.	1476
4. Check minimum number of events None	1476
5. Include endpoints None	1476
6. Filter based on genotype QC (FinnGen only)	1476

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: D14
Name in latin: Neoplasma benignum auris mediae

NAME	CD2_BENIGN_EAR_NASAL_SINUS
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D140
HD_ICD_9	2120
HD_ICD_8	2120
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D140
COD_ICD_9	2120
COD_ICD_8	2120
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Benign neoplasm: Middle ear, nasal cavity and accessory sinuses based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	9658	4526	5061
Only index persons	8673	4172	4501
Unadjusted period prevalence (%)
Whole population	0.14	0.13	0.14
Only index persons	0.16	0.15	0.17
Median age at first event (years)
Whole population	53.85	54.43	53.29
Only index persons	52.85	53.43	52.31

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1476	692	784
Unadjusted period prevalence (%)	0.29	0.24	0.35
Median age at first event (years)	56.09	54.05	57.89

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1324: Matched controls
13240

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

D14.0

ICD-10 Finland

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

+∞

323.0

1167

DHB10

NOMESCO Finland

Excision of lesion of internal nose

434.1

225.7

220

DHA10

NOMESCO Finland

Biopsy of cavity of nose

96.2

218.2

238

UDH02

NOMESCO Finland

Rhinopharyngoscopy

13.2

206.1

391

408

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

10.2

126.0

266

317

B97.7

ICD-10 Finland

Papillomavirus as the cause of diseases classified to other chapters

146.4

114.2

120

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

11.2

98.4

195

201

UDM02

NOMESCO Finland

Sinoscopy

17.3

95.0

154

100

DNB20

NOMESCO Finland

Endoscopic ethmoidectomy

13.2

92.4

168

144

2120A

ICD-9 Finland

Benign neoplasm of respiratory and intrathoracic organs, Nasal cavities, middle ear and accessory sinuses

+∞

89.6

J33.0

ICD-10 Finland

Polyp of nasal cavity

11.1

74.9

148

149

DM1BD

NOMESCO Finland

Extensive CT of paranasal sinuses and face area

74.5

74.2

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

5.6

72.9

232

482

DPA25

NOMESCO Finland

Trephine of frontal sinus through nose

34.0

56.7

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

4.3

54.9

225

601

DHB20

NOMESCO Finland

Polypectomy of internal nose

16.1

54.1

R01AD08

ATC

fluticasone; nasal

2.7

51.5

476

2304

DM1DG

NOMESCO Finland

Paranasal sinuses and face area very extensive MRI examination with high intensity magnet

180.2

50.3

J33.8

ICD-10 Finland

Other polyp of sinus

9.9

49.8

103

112

DNB30

NOMESCO Finland

Excision of lesion of ethmoidal sinus

+∞

49.3

DPA30

NOMESCO Finland

Sphenotomy

30.1

49.2

C30.0

ICD-10 Finland

Malignant neoplasm: Nasal cavity

127.1

46.1

TDM10

NOMESCO Finland

Puncture of maxillary antrum

6.4

44.4

122

206

DHB40

NOMESCO Finland

Conchotomy

72.5

43.3

R01AD09

ATC

mometasone; nasal

2.2

41.7

649

3985

WX408

NOMESCO Finland

General anesthesy, balanced

2.4

41.4

450

2318

DMB10

NOMESCO Finland

Radical maxillary antrotomy

31.2

40.8

21200

ICD-8 Finland

Benign neoplasm of respiratory system, Cavi nasi

+∞

35.6

DMB30

NOMESCO Finland

Transmaxillary excision of lesion of maxillary antrum

126.8

34.9

DMB00

NOMESCO Finland

Endonasal trephine of maxillary antrum

17.3

34.8

21202

ICD-8 Finland

Benign neoplasm of respiratory system, Sinus maxillaris

+∞

34.5

4256

FHL

Nasal or sinus tumor removal

+∞

34.5

D14.1

ICD-10 Finland

Benign neoplasm: Larynx

17.2

33.5

DJW00

NOMESCO Finland

Removal of local lesion of nasal septum

335.1

33.0

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

7.8

32.7

104

J33.9

ICD-10 Finland

Nasal polyp, unspecified

13.5

32.1

ZXC10

NOMESCO Finland

Use of laser

8.0

30.8

DHB00

NOMESCO Finland

Excision of lesion of external nose

14.9

29.4

J31.0

ICD-10 Finland

Chronic rhinitis

3.4

27.7

145

466

R04.0

ICD-10 Finland

Epistaxis

3.2

26.3

148

500

DKW40

NOMESCO Finland

Ligature of artery of internal nose

51.1

25.3

DMB35

NOMESCO Finland

Endoscopic excision of neoplasm or another lesion from maxillary sinus

+∞

25.1

R01AD12

ATC

fluticasone furoate; nasal

2.0

24.7

393

2296

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.8

24.4

674

4794

J34.8

ICD-10 Finland

Other specified disorders of nose and nasal sinuses

9.9

24.4

D36.7

ICD-10 Finland

Benign neoplasm: Other specified sites

49.3

24.3

B977, D140

ICD-10 Finland

+∞

23.0

UDQ12

NOMESCO Finland

Flexible laryngoscopy

3.4

22.8

115

358

WX110

NOMESCO Finland

Local anesthesy

1.8

21.2

881

6996

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.0

21.2

300

1656

DNB40

NOMESCO Finland

Sublabial rhinotomy

111.8

20.6

DM1CG

NOMESCO Finland

Paranasal sinuses and face area extensive MRI examination with high intensity magnet

33.1

20.2

ZXC95

NOMESCO Finland

Use of surgical navigator

10.0

20.2

DMA00

NOMESCO Finland

Biopsy of maxillary antrum

36.4

19.9

H02AB06

ATC

prednisolone; systemic

1.7

19.6

622

4504

J01.0

ICD-10 Finland

Acute maxillary sinusitis

2.0

19.4

287

1607

ZXA05

NOMESCO Finland

Left side

1.9

19.3

368

2264

CCD60

NOMESCO Finland

Transnasal dacryocystorhinostomy

17.4

18.7

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

4.2

18.2

178

DQB10

NOMESCO Finland

Endoscopic excision of lesion of larynx

8.3

17.8

J32.1

ICD-10 Finland

Chronic frontal sinusitis

20.4

17.8

J34.2

ICD-10 Finland

Deviated nasal septum

3.2

17.4

298

WX002

NOMESCO Finland

Sedation and analgesia

1.9

17.0

285

1664

8070/3-C30.0

ICD-O-3

Squamous cell carcinoma, NOS, of nasal cavity

+∞

16.7

DHB50

NOMESCO Finland

Turbinoplasty

4.5

16.1

131

J01DB01

ATC

cefalexin; oral

1.7

15.9

1041

8985

J34.1

ICD-10 Finland

Cyst and mucocele of nose and nasal sinus

6.1

15.8

J01CA04

ATC

amoxicillin; systemic

1.7

15.4

1009

8654

WX402

NOMESCO Finland

General anaesthesia

2.0

15.3

225

1245

DJA10

NOMESCO Finland

Biopsy of septum of nose

57.3

14.8

DPW99

NOMESCO Finland

Other operation on frontal or sphenoidal sinus

21.3

14.7

D38.50

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour of maxillary sinus

151.6

14.5

DPB00

NOMESCO Finland

Partial excision of frontal sinus

30.4

13.9

ZXA00

NOMESCO Finland

Right side

1.7

13.7

377

2549

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

3.3

13.6

217

QA1S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in head

16.4

13.5

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.8

13.3

242

1441

ZXA10

NOMESCO Finland

Bilateral

1.8

13.3

253

1530

UDQ22

NOMESCO Finland

Microlaryngoscopy

8.6

13.3

J01AA02

ATC

doxycycline; systemic

1.6

13.2

984

8501

R01AD01

ATC

beclometasone; nasal

1.9

13.1

204

1150

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.6

13.0

554

4185

DPA20

NOMESCO Finland

Trephine of frontal sinus

22.8

12.9

D10.6

ICD-10 Finland

Benign neoplasm: Nasopharynx

17.5

12.5

DMB40

NOMESCO Finland

Excision of lesion of maxillary antrum trough lateral rhinotomy

+∞

12.5

4226

FHL

Posterior radical surgery and possible etmoidectomy

9.4

12.5

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.6

12.3

490

3630

N02BE01

ATC

paracetamol; systemic, rectal

1.7

12.2

1082

9646

R08

ICPC

Nose symptom/complaint other

3.5

12.1

165

J01FA10

ATC

azithromycin; systemic

1.5

12.0

682

5464

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

6.6

11.6

D38.51

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour of other accessory sinus

121.0

11.4

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

11.3

567

4396

J32.4

ICD-10 Finland

Chronic pansinusitis

5.0

10.9

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

3.2

10.6

178

J45.9

ICD-10 Finland

Asthma, unspecified

1.7

10.3

218

1355

D38.58

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour of other respiratory organ

32.8

10.3

DMA10

NOMESCO Finland

Exploration of maxillary antrum

23.6

10.2

DQA10

NOMESCO Finland

Biopsy of larynx

10.1

10.0

J30.4

ICD-10 Finland

Allergic rhinitis, unspecified

3.5

9.8

128

SAA03

NOMESCO Finland

Extended examination of mouth

1.5

9.7

438

3294

R06AX22

ATC

ebastine; oral

1.7

9.6

200

1234

D11.0

ICD-10 Finland

Benign neoplasm: Parotid gland

4.4

9.6

C31.0

ICD-10 Finland

Malignant neoplasm: Maxillary sinus

100.7

9.4

R4110

NOMESCO Finland

Physiotherapy

1.6

9.4

324

2288

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.6

9.4

271

1835

DPB10

NOMESCO Finland

Partial excision of sphenoidal sinus

+∞

9.4

DPC35

NOMESCO Finland

Extensive endoscopic excision of lesion or neoplasm extending to more than one paranasal sinus

+∞

9.4

UDC00

NOMESCO Finland

Ear microscopy

2.1

9.2

105

524

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.5

9.1

348

2517

A02BC02

ATC

pantoprazole; systemic

1.4

9.0

783

6663

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

7.1

9.0

J33

ICD-10 Finland

Nasal polyp

10.1

9.0

TPH04

NOMESCO Finland

Cathetrisation of vein

1.6

8.9

256

1728

R51.81

ICD-10 Finland

Facial pain NOS

3.7

8.8

103

4222

FHL

Endonasal etmoidectomy

7.2

8.7

R06AE07

ATC

cetirizine; oral

1.4

8.6

490

3839

R03AC02

ATC

salbutamol; inhalant

1.4

8.6

608

4962

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.7

8.6

202

1291

J01.1

ICD-10 Finland

Acute frontal sinusitis

4.5

8.6

XX3DW

NOMESCO Finland

Time consuming IT work

1.9

8.5

131

734

S01GX01

ATC

cromoglicic acid; ophthalmic

1.6

8.4

209

1354

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.5

8.4

406

3074

A06AC01

ATC

ispaghula (psylla seeds); oral

1.5

8.4

282

1975

DKW30

NOMESCO Finland

Cauterisation of artery of internal nose

6.8

8.4

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.5

8.3

248

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

1.9

8.3

122

671

A07AA02

ATC

nystatin; oral

2.2

8.3

407

EP1CG

NOMESCO Finland

Extensive MRI examination of soft tissue of neck with high intesity magnet

5.0

8.2

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

8.2

438

3382

4239

FHL

Other measure in this category

9.0

8.0

J32.8

ICD-10 Finland

Other chronic sinusitis

10.1

8.0

M01AE01

ATC

ibuprofen; systemic, rectal

1.5

8.0

1105

10158

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

2.4

7.9

293

J01MA12

ATC

levofloxacin; systemic

1.6

7.8

226

1526

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.7

7.7

170

1065

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.4

7.7

377

2855

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

7.6

253

1764

M31.3

ICD-10 Finland

Wegener granulomatosis

11.9

7.6

WF002

NOMESCO Finland

Radical radiotherapy

2.3

7.6

307

YA1VG

NOMESCO Finland

MRI examination of head and neck with high intesity magnet for dose design of radiotherapy

10.1

7.5

R22.0

ICD-10 Finland

Localized swelling, mass and lump, head

2.8

7.5

169

B07.9

ICD-10 Finland

Verruca simplex

2.8

7.5

163

J01FF01

ATC

clindamycin; systemic

1.5

7.5

319

2347

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

7.3

804

6999

21208

ICD-8 Finland

Benign neoplasm of respiratory system, Nasi, loco multiplici

+∞

7.3

DJB10

NOMESCO Finland

Excision of septum of nose

+∞

7.3

C72.2

ICD-10 Finland

Malignant neoplasm: Olfactory nerve

+∞

7.3

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

7.3

302

2209

KMAK

NOMESCO Finland

1.4

7.2

577

4767

DCB00

NOMESCO Finland

Excision of lesion of middle ear

30.2

7.2

A02BC03

ATC

lansoprazole; oral

1.4

7.1

346

2608

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

7.1

191

1264

DJD20

NOMESCO Finland

Plastic repair of septum of nose

2.6

7.1

200

WF003

NOMESCO Finland

Adjuvant radiotherapy

2.5

7.0

201

A02BC05

ATC

esomeprazole; systemic

1.4

7.0

467

3735

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

2.1

7.0

375

H65.3

ICD-10 Finland

Chronic mucoid otitis media

3.4

6.9

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

3.6

6.8

DKW99

NOMESCO Finland

Other procedures for control of epistaxis

9.4

6.8

R03DC03

ATC

montelukast; oral

1.6

6.8

173

1128

ZXC99

NOMESCO Finland

Other special technic in surgery

16.8

6.7

SAA04

NOMESCO Finland

Special inverstigation of mouth

2.2

6.7

319

ZZC00

NOMESCO Finland

Graft of fascia

22.6

6.7

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.9

6.7

510

N02AX02

ATC

tramadol; systemic, rectal

1.4

6.7

505

4116

50300

ICD-8 Finland

Chronic sinusitis, Maxillaris cum empyemate

6.5

6.6

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.6

6.6

183

1222

UDQ02

NOMESCO Finland

Direct laryngoscopy

4.8

6.5

R09

ICPC

Sinus symptom/complaint

2.0

6.5

405

4711A

ICD-9 Finland

Nasal polyps, Polypoid sinus degeneration

6.9

6.5

G50.1

ICD-10 Finland

Atypical facial pain

3.5

6.5

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

6.5

465

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.9

6.5

511

DM1CD

NOMESCO Finland

Very extensive CT of paranasal sinuses and face area

70.2

6.4

QAE99

NOMESCO Finland

Other excision or repair surgery of skin and subcutaneous tissue in head and neck

3.0

6.4

116

N05CF01

ATC

zopiclone; oral

1.4

6.3

368

2860

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

6.3

531

4386

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

6.3

706

6095

EMA30

NOMESCO Finland

Biopsy of rhinopharynx

11.1

6.3

J01DA01

ATC

[U] cefalexin; systemic

1.3

6.3

752

6560

Z01.2

ICD-10 Finland

Dental examination

1.4

6.3

441

3539

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.0

6.3

384

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

1.9

6.3

517

9522/3-C30.0

ICD-O-3

Olfactory neuroblastoma of nasal cavity

+∞

6.3

AAE05

NOMESCO Finland

Nasoendoscopic closure of cerebrospinal fluid fistula

+∞

6.3

21209

ICD-8 Finland

Benign neoplasm of respiratory system, Nasi, NUD

+∞

6.3

B977, D141

ICD-10 Finland

+∞

6.3

DM1BG

NOMESCO Finland

Paranasal sinuses and face area standard MRI examination with high intensity magnet

+∞

6.3

DPB20

NOMESCO Finland

Obliteration of frontal sinus

+∞

6.3

J01

ICD-10 Finland

Acute sinusitis

2.2

6.2

262

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.3

6.2

588

4945

K02.1

ICD-10 Finland

Caries of dentine

1.3

6.2

624

5299

J01FA09

ATC

clarithromycin; systemic

1.4

6.1

351

2716

R01BA52

ATC

pseudoephedrine, combinations; oral

1.4

6.1

341

2626

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.4

6.1

385

3030

DKW10

NOMESCO Finland

Packing of anterior cavity of nose

12.6

6.1

M54.4

ICD-10 Finland

Lumbago with sciatica

1.6

6.1

179

1209

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.8

6.1

521

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

2.6

6.1

155

H04.4

ICD-10 Finland

Chronic inflammation of lacrimal passages

10.1

6.0

UJH02

NOMESCO Finland

Anoscopy

2.2

6.0

252

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.6

6.0

156

G47.3

ICD-10 Finland

Sleep apnoea

1.5

6.0

253

1847

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(40768804) Tissue Pathology biopsy report

798

4705

2.52

65.14

2.8

2.1

—

(3007853) Bacteria identified in Skin by Aerobe culture

271

1421

2.11

24.72

2.0

1.7

—

(4035726)

218

1063

2.23

23.85

1.5

1.4

—

(3042936) Bacteria identified in Isolate by Culture

307

1790

1.90

20.39

2.1

—

(3030467) Casts [#/volume] in Urine by Automated count

489

3361

1.68

18.21

3.4

3.2

e6/l

0.4

0.5

0.69

362

2585

(36304419) Bacteria [Presence] in Urine

476

3252

1.68

18.12

3.2

3.1

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

691

5202

1.62

17.81

5.0

g/l

35.3

35.4

0.10

644

4836

(3002256) Pathology report gross observation

262

1529

1.87

17.10

1.3

—

(3002582) Erythrocytes [#/volume] in Urine

518

3681

1.63

16.59

3.5

3.3

e6/l

92.4

89.1

0.02

384

2887

(3018418) pH of Serum or Plasma

505

3571

1.63

16.47

4.5

4.0

7.4

0.12

698

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

712

5465

1.59

16.47

6.6

6.2

mmol/l

1.2

1.01

668

4944

(3018095) Leukocytes [#/volume] in Urine

577

4246

1.59

15.79

4.1

3.7

e6/l

68.4

120.1

0.94

403

3091

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1086

9292

1.64

15.17

8.6

7.7

u/l

79.6

79.1

0.14

1021

8735

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

228

1356

1.81

13.81

2.6

2.7

umol/l

5.8

8.7

3.74

198

1200

(3044889) 12 lead EKG panel

1007

8547

1.56

13.71

4.3

3.9

—

(42870588) Differential panel, method unspecified - Blood

547

4078

1.54

13.61

6.2

5.8

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

785

6356

1.50

13.00

6.3

umol/l

12.0

11.7

0.19

743

6040

(3033658) Prothrombin time (PT) actual/Normal

427

3042

1.57

12.87

4.5

3.9

89.6

88.8

0.32

418

2975

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

748

6015

1.49

12.69

7.4

7.0

mmol/l

1.2

0.86

625

5054

(3013707) Erythrocyte sedimentation rate by Westergren method

1027

8862

1.52

12.01

4.5

4.1

mm/h

13.2

12.4

0.83

957

8168

(3013650) Neutrophils [#/volume] in Blood by Automated count

835

6909

1.48

12.01

9.8

9.1

e9/l

4.3

4.2

1.04

715

6048

(40758558) Short blood count panel - Blood

418

3008

1.54

11.89

7.8

6.6

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

306

2061

1.61

11.55

3.1

2.8

e6/l

0.7

1.1

2.33

178

1205

(3001604) Monocytes [#/volume] in Blood

729

5917

1.46

11.29

6.8

5.8

e9/l

0.6

1.34

610

5107

(3006315) Basophils [#/volume] in Blood

730

5938

1.45

11.11

6.9

5.8

e9/l

0.0

0.12

610

5140

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

324

2236

1.58

10.98

2.9

3.1

mmol/l

2.4

2.5

0.08

274

1970

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

289

1946

1.60

10.86

3.3

2.9

e6/l

2.1

2.2

0.04

159

1094

(3002385) Erythrocyte distribution width [Ratio]

1108

9811

1.52

10.63

22.0

18.0

13.8

13.7

0.64

1090

9586

(3000494) Fungus identified in Specimen by Culture

227

1451

1.67

10.48

1.7

1.4

—

(3006504) Eosinophils/100 leukocytes in Blood

686

5558

1.44

10.43

7.0

6.0

3.0

2.9

1.10

634

5172

(3019069) Monocytes/100 leukocytes in Blood

688

5581

1.44

10.37

7.2

6.3

8.7

0.01

641

5214

(3019198) Lymphocytes [#/volume] in Blood

738

6071

1.43

10.26

6.9

5.9

e9/l

1.9

0.22

633

5344

(3031040) Bacteria [#/volume] in Urine by Automated count

912

7801

1.44

10.20

5.0

4.4

e6/l

3301.9

1777.5

—

113

(3013115) Eosinophils [#/volume] in Blood

745

6143

1.43

10.20

7.1

6.1

e9/l

0.2

1.16

642

5403

(3021589) Normoblasts [#/volume] in Blood

656

5293

1.43

10.09

10.8

9.8

e9/l

0.0

0.44

521

4348

(3002030) Lymphocytes/100 leukocytes in Blood

699

5714

1.42

9.95

7.1

6.1

27.0

27.4

0.45

645

5319

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

180

1107

1.71

9.57

2.9

2.4

u/l

33.5

38.4

0.45

150

943

(3022096) Basophils/100 leukocytes in Blood

664

5409

1.41

9.49

7.1

6.0

0.7

0.05

616

5043

(3000850) Epithelial cells [#/volume] in Urine

355

2576

1.50

9.38

2.6

e6/l

4.1

5.3

1.57

297

2279

(3026782) Osmolality of Urine

338

2440

1.50

9.13

3.1

2.7

mosm/kgh2o

549.2

553.2

0.12

281

2086

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

683

5645

1.39

8.71

3.9

4.1

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1284

11893

1.61

8.64

18.9

14.8

mg/l

23.4

25.0

1.10

1078

9444

(3018010) Neutrophils/100 leukocytes in Blood

680

5623

1.39

8.61

7.0

5.9

57.3

57.6

0.26

630

5258

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

3.65

8.58

1.3

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

514

4065

1.41

8.44

3.2

3.4

mmol/l

2.4

0.17

459

3540

(3012095) Magnesium [Moles/volume] in Serum or Plasma

277

1958

1.51

8.20

4.2

3.4

mmol/l

0.8

0.17

258

1839

(3023368) Bacteria identified in Blood by Culture

442

3425

1.41

8.09

4.9

4.4

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

611

5004

1.38

8.03

2.1

2.0

pmol/l

94.8

94.0

0.16

311

2633

(3013826) Glucose [Moles/volume] in Serum or Plasma

830

7142

1.37

7.98

5.5

5.0

mmol/l

6.8

0.01

782

6711

(3023419) Bacteria identified in Sputum by Culture

160

2.67

7.92

2.4

2.6

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

1318

12348

1.63

7.72

21.2

17.2

mmol/l

139.6

139.7

0.68

1302

12021

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1179

10788

1.46

7.71

5.1

4.6

mu/l

1.9

2.2

1.10

1090

9809

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1227

11318

1.50

7.68

17.1

13.7

ml/min/173m2

80.3

79.8

0.30

1047

9389

(3023103) Potassium [Moles/volume] in Serum or Plasma

1319

12383

1.61

7.37

21.3

17.3

mmol/l

4.0

1.66

1300

12039

(3037467) Urinalysis macro (dipstick) panel - Urine

927

8180

1.36

7.23

4.8

4.3

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

209

1428

1.54

7.20

3.9

4.1

u/l

249.7

248.8

0.03

195

1354

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

999

8924

1.37

7.17

4.3

3.9

pmol/l

14.8

14.9

0.38

919

8066

(3011397) Hemoglobin [Presence] in Urine by Test strip

353

2680

1.42

7.12

4.2

3.6

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

129

790

1.69

6.96

1.3

1.4

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

526

1.84

6.91

2.8

1.4

u/ml

10.9

10.6

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

268

2.17

6.83

1.5

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

140

883

1.65

6.76

1.6

1.7

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

476

3845

1.35

6.49

2.5

u/l

57.9

57.4

0.10

443

3564

(3005719) IgG [Mass/volume] in Serum or Plasma

143

919

1.62

6.41

2.7

2.8

g/l

10.4

10.7

0.42

129

840

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

108

645

1.73

6.40

10.2

10.4

mmol/l

24.7

24.4

0.32

608

(3036481) Cortisol [Moles/volume] in Serum or Plasma

162

1077

1.57

6.30

3.2

2.2

nmol/l

365.1

366.8

0.04

156

986

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

574

1.76

6.22

4.0

3.7

mmol/l

24.4

24.1

0.45

518

(3044640) Blood type and Crossmatch panel - Blood

472

3833

1.34

6.14

2.4

2.5

—

(3032080) INR in Blood by Coagulation assay

600

5053

1.32

6.03

10.7

9.9

inr

1.3

0.09

174

1486

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

573

4796

1.32

6.01

2.4

2.2

nmol/l

77.5

77.1

0.11

515

4276

(3000991) Gas panel - Venous blood

156

1040

1.56

5.99

9.3

8.5

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

200

1426

1.47

5.58

7.9

8.1

kpa

5.1

0.11

191

1361

(3027801) Oxygen [Partial pressure] in Arterial blood

200

1427

1.46

5.56

7.9

8.1

kpa

13.0

12.0

1.30

190

1364

(40761511) CBC panel - Blood by Automated count

1308

12389

1.49

5.55

16.1

14.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

322

1.93

5.42

1.3

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

454

3722

1.32

5.40

2.0

2.2

u/l

188.6

228.0

0.67

428

3503

(40768797) Stomach Pathology biopsy report

230

1699

1.42

5.31

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

125

2.51

5.30

4.2

3.5

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1336

12729

1.52

5.29

12.2

10.6

u/l

26.2

26.7

0.72

1298

12263

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

334

1.89

5.19

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

334

1.89

5.19

1.2

—

(3052851) Hemolysis interference index of Serum or Plasma

357

1.86

5.14

2.7

3.5

—

(3003396) Base excess in Arterial blood by calculation

198

1432

1.44

5.13

8.0

8.1

mmol/l

1.3

1.2

0.19

157

1119

(46235355) HIV 1 and 2 tests - Meaningful Use set

235

1756

1.40

5.07

1.7

—

(3009542) Hematocrit [Volume Fraction] of Blood

1160

10809

1.34

5.02

20.0

15.7

40.3

39.9

1.20

841

7591

(42529406) Shigella sp [Presence] in Stool by Culture

338

1.87

5.02

1.2

—

(40768443) Skin Pathology biopsy report

510

1.71

5.00

1.2

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

234

1754

1.40

4.96

1.5

1.4

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

194

1410

1.43

4.89

1.9

1.8

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

298

2332

1.35

4.82

4.4

3.8

ng/l

281.5

376.5

0.38

230

1846

(3048689) Calprotectin [Mass/mass] in Stool

185

1337

1.44

4.81

2.1

2.3

ug/g

152.2

138.6

0.22

148

1062

(3035350) Ketones [Presence] in Urine by Test strip

662

5776

1.26

4.68

4.3

3.7

estimate

0.0

0.00

134

1110

(3003458) Phosphate [Moles/volume] in Serum or Plasma

217

1623

1.40

4.65

5.2

5.8

mmol/l

1.0

0.02

201

1503

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

148

1033

1.48

4.61

2.9

ng/l

208.0

205.8

0.02

136

944

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

191

1400

1.42

4.60

1.9

1.7

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

248

1900

1.37

4.59

2.5

2.1

30.2

29.8

0.36

241

1839

(3000492) Spirometry study

164

1173

1.45

4.51

1.6

1.5

—

(3007461) Platelets [#/volume] in Blood

1374

13236

1.55

4.42

26.9

21.7

e9/l

247.6

247.3

0.06

1352

12889

(3001122) Ferritin [Mass/volume] in Serum or Plasma

577

4977

1.26

4.42

3.3

2.8

ug/l

152.6

141.0

0.24

541

4559

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

376

3077

1.30

4.40

2.5

2.2

mg/l

3.1

3.0

0.08

326

2603

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

2.84

4.39

2.2

2.3

—

(3024731) MCV [Entitic volume]

1374

13239

1.55

4.38

26.8

21.6

91.0

91.2

0.60

1366

13025

(3026361) Erythrocytes [#/volume] in Blood

1374

13242

1.54

4.34

26.9

21.6

e12/l

4.5

0.15

1347

12855

(3000963) Hemoglobin [Mass/volume] in Blood

1374

13245

1.54

4.30

27.1

21.8

g/l

135.2

135.8

0.67

1366

13029

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

178

1305

1.41

4.28

3.8

3.4

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

465

3922

1.27

4.27

3.5

3.3

u/l

34.4

34.1

0.03

442

3728

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

784

7024

1.25

4.25

2.9

2.8

—

(3035941) MCH [Entitic mass]

1373

13241

1.53

4.20

26.8

21.5

30.3

30.4

1.52

1365

13025

(3026389) Candida sp identified in Specimen by Organism specific culture

153

2.18

4.20

1.1

1.4

—

(3010813) Leukocytes [#/volume] in Blood

1373

13244

1.53

4.16

27.0

21.7

e9/l

7.0

6.7

2.31

1347

12855

(4062490)

103

2.45

4.14

2.2

1.3

—

(3009261) Glucose [Presence] in Urine by Test strip

665

5861

1.25

4.14

4.3

3.7

estimate

0.0

1.08

133

1081

(3024980) IgG subclass 4 [Mass/volume] in Serum

174

2.10

4.13

2.4

1.6

g/l

0.8

0.06

131

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

220

1682

1.36

4.12

2.7

2.6

20.9

23.1

1.70

194

1441

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

162

2.12

4.05

1.2

1.3

nmol/l

0.6

0.7

0.27

153

(3026493) Urate [Moles/volume] in Serum or Plasma

389

3230

1.28

4.02

3.1

2.8

umol/l

6305.8

6289.9

0.00

332

2794

(3017143) Hepatitis C virus Ab [Presence] in Serum

166

1218

1.41

3.98

1.5

1.6

—

(3022217) INR in Platelet poor plasma by Coagulation assay

212

1620

1.36

3.98

27.2

25.7

inr

1.4

0.19

223

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

2.50

3.97

1.3

1.2

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1180

11127

1.30

3.96

6.3

5.9

mmol/mol

40.1

0.08

1106

10281

(3003327) Ova and parasites identified in Stool by Light microscopy

335

1.76

3.96

1.5

1.7

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1230

11669

1.32

3.91

4.9

4.6

mmol/l

6.0

0.29

1148

10581

(3024928) Oxygen saturation in Venous blood

270

1.84

3.90

2.5

2.8

—

(3021601) Nitrite [Presence] in Urine by Test strip

655

5791

1.24

3.88

5.7

5.0

estimate

0.0

0.00

140

1125

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

866

7887

1.24

3.88

3.2

u/l

46.4

51.9

1.31

812

7343

(3016502) Oxygen saturation in Arterial blood

173

1285

1.39

3.87

8.6

95.6

0.08

165

1237

(3024139) IgG subclass 3 [Mass/volume] in Serum

101

2.40

3.82

2.1

1.3

g/l

0.3

0.4

0.22

(3027135) IgG subclass 1 [Mass/volume] in Serum

101

2.40

3.82

2.1

1.3

g/l

7.0

7.2

0.10

(3028192) IgG subclass 2 [Mass/volume] in Serum

101

2.40

3.82

2.1

1.3

g/l

3.4

2.8

0.77

(3028026) IgM [Mass/volume] in Serum or Plasma

108

736

1.50

3.81

1.7

1.8

g/l

1.4

0.08

679

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

153

2.12

3.80

1.2

1.3

—

(3012544) pH of Venous blood

162

1198

1.40

3.72

4.1

3.6

—

7.4

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

193

1470

1.36

3.70

1.5

1.6

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

253

2009

1.31

3.66

2.0

1.8

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

323

2650

1.28

3.64

1.9

1.7

mg/l

1.3

1.2

0.30

267

2037

(3022948) Iron [Moles/volume] in Serum or Plasma

245

1939

1.32

3.63

2.6

2.5

umol/l

11.7

13.0

2.02

229

1792

(3002173) Hemoglobin [Mass/volume] in Arterial blood

161

1195

1.39

3.62

9.1

9.0

g/l

119.7

121.6

0.50

154

1153

(3004716) Salmonella sp identified in Stool by Organism specific culture

542

1.56

3.57

1.3

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

382

3210

1.26

3.52

1.7

mmol/l

1.5

1.4

0.86

318

2664

(3004789) Transferrin [Mass/volume] in Serum or Plasma

226

1780

1.32

3.46

2.6

2.5

g/l

2.3

0.09

210

1652

(3014007) Fractional oxyhemoglobin in Arterial blood

112

786

1.46

3.44

10.3

9.7

93.6

93.8

0.21

112

779

(3042111) Morphology [Interpretation] in Bone marrow Narrative

216

1.88

3.42

1.4

1.6

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

111

782

1.45

3.35

10.3

9.7

0.6

0.7

0.53

111

776

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

104

724

1.47

3.34

1.5

—

(3027945) Reticulocytes/100 erythrocytes in Blood

183

1406

1.34

3.32

2.3

2.6

1.8

0.05

169

1259

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

255

1.79

3.32

1.5

1.7

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

352

2952

1.25

3.28

2.4

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

372

1.64

3.22

1.5

1.7

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

207

1.86

3.19

1.1

1.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

144

2.03

3.17

1.0

u/ml

0.7

4.0

—

(3007164) IgA [Mass/volume] in Serum or Plasma

270

2203

1.28

3.16

1.6

1.4

g/l

2.4

2.5

0.36

160

1362

(3023323) Follitropin [Units/volume] in Serum or Plasma

375

1.63

3.13

1.4

iu/l

30.5

27.4

0.30

316

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

678

1.46

3.07

10.5

11.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

251

1.73

2.91

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

251

1.73

2.91

1.3

—

(40760892) CBC W Ordered Manual Differential panel - Blood

310

2596

1.25

2.90

5.2

4.6

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

2.26

2.87

1.3

1.2

u/ml

0.4

0.8

—

(3012501) Base excess in Blood by calculation

284

1.68

2.82

3.1

5.0

mmol/l

2.6

2.5

0.13

194

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

2.78

2.82

3.7

2.6

—

(3014051) Protein [Presence] in Urine by Test strip

269

1.69

2.81

1.8

2.2

—

(3002032) Base excess in Venous blood by calculation

151

1158

1.34

2.80

4.2

3.5

mmol/l

2.0

0.07

131

922

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

145

1.95

2.76

1.1

1.3

nmol/l

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

104

2.13

2.75

1.1

1.2

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

203

1.79

2.75

1.5

1.4

—

(40768795) Lymph node Pathology biopsy report

111

2.09

2.73

1.3

1.1

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

105

2.11

2.69

2.0

1.6

—

(3022145) Colonoscopy Study observation

172

1354

1.31

2.66

1.2

1.3

—

(3035637) Corticotropin [Mass/volume] in Plasma

133

1.97

2.66

1.8

1.6

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

133

1010

1.35

2.64

3.5

3.9

mmol/l

1.2

0.36

120

872

(3021387) Prolactin [Units/volume] in Serum or Plasma

313

1.62

2.64

2.1

1.6

mu/l

278.5

284.9

0.07

282

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

2.40

2.63

1.7

1.2

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

2.40

2.63

1.7

1.2

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

291

1.64

2.59

1.6

1.3

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

331

1.59

2.57

1.8

2.1

mg/l

10.5

11.9

0.75

304

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

5.47

2.54

1.2

1.0

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1235

11872

1.25

2.53

4.7

4.5

mmol/l

4.5

4.6

2.12

1160

10946

(3009214) Lutropin [Units/volume] in Serum or Plasma

278

1.64

2.51

1.2

1.4

u/l

10.4

9.1

0.22

225

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1226

11783

1.24

2.47

4.6

4.4

mmol/l

1.4

3.84

1143

10788

(1002224) Polysomnography panel

473

1.48

2.46

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

174

1.80

2.43

1.1

u/ml

1.5

1.9

0.12

(3003888) Timothy IgE Ab [Units/volume] in Serum

153

1.85

2.39

1.0

u/ml

4.5

5.1

0.10

(3007566) Smooth muscle Ab [Titer] in Serum

330

1.56

2.37

1.1

1.2

titre

48.3

84.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

4.13

2.36

1.3

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

4.13

2.36

1.3

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

4.13

2.36

1.3

1.0

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

416

3658

1.19

2.35

3.0

ng/l

1199.7

1394.8

0.63

366

3129

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

300

1.59

2.32

1.1

1.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

101

751

1.37

2.32

1.2

—

(3023520) Reticulocytes [#/volume] in Blood

136

1059

1.31

2.30

2.3

2.8

e9/l

76.1

70.0

1.04

102

824

(4010399)

114

866

1.34

2.29

1.5

1.4

—

(3021788) Differential panel - Synovial fluid

232

1.65

2.25

1.5

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

287

1.59

2.24

1.2

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

3.12

2.22

1.3

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

127

985

1.32

2.22

2.2

2.3

nmol/l

12.7

13.0

0.18

113

873

(3026008) Bacteria identified in Urine by Culture

403

3550

1.19

2.22

3.4

3.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

5.57

2.21

1.4

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

150

1.81

2.21

1.0

u/ml

0.5

1.9

0.94

(3021960) Folate [Moles/volume] in Serum or Plasma

334

2895

1.20

2.20

1.6

nmol/l

19.8

20.5

0.39

298

2460

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

655

1.38

2.19

2.6

3.4

pmol/l

4.3

4.5

1.16

572

(3045414) Leukocytes [Presence] in Urine

528

1.42

2.18

1.7

1.8

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

520

1.42

2.17

2.1

2.0

u/l

36.5

39.2

0.65

461

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

588

1.40

2.16

2.0

1.8

g/l

1.6

0.29

514

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

3.70

2.15

1.0

1.3

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1251

12097

1.22

2.09

5.3

5.0

mmol/l

2.7

1.94

1172

11078

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

123

964

1.30

2.01

1.9

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

170

1.72

2.01

1.1

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

123

966

1.30

1.99

3.0

2.7

ml/min/173m2

67.1

64.7

0.24

400

(3019060) Gas panel - Arterial blood

109

844

1.31

1.95

4.1

5.5

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

164

1.72

1.95

1.0

1.1

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

242

1.59

1.94

2.9

3.6

58.0

57.4

0.14

242

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1182

11396

1.19

1.89

4.1

4.0

mmol/l

1.4

1.3

2.60

1088

10377

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

450

1.42

1.88

2.7

2.5

g/l

10.6

0.01

385

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

622

1.35

1.86

2.4

—

(3042631) Mycobacterium sp identified in Specimen

182

1.66

1.86

2.3

2.5

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

2.40

1.85

1.1

1.8

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

101

1.89

1.81

1.5

1.6

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

3.05

1.80

1.3

1.1

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

102

1.87

1.76

1.4

1.1

titre

134.0

145.3

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

2.10

1.76

1.9

2.0

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

1.91

1.75

2.4

1.5

—

(3011648) Oxygen content in Venous blood

1.91

1.75

1.9

2.0

12.9

10.6

0.82

(1616796) Gas panel - Central venous blood

281

1.51

1.75

2.2

4.1

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

233

1.56

1.74

2.9

3.3

e9/l

4.2

4.4

0.18

233

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

449

1.40

1.73

2.5

2.7

—

(40761536) Microorganisms panel - Urine sediment

129

1040

1.26

1.72

4.0

3.9

—

(3020630) Protein [Mass/volume] in Serum or Plasma

129

1041

1.26

1.71

2.6

2.8

g/l

64.9

66.5

1.86

119

949

(3036670) Protein [Mass/volume] in Synovial fluid

0.00

1.71

0.0

1.2

—

36.5

—

(3004588) Protein electrophoresis panel - Serum or Plasma

110

871

1.28

1.70

2.6

2.5

—

(3017181) Myelocytes/100 leukocytes in Blood

126

1015

1.26

1.70

4.2

4.3

0.9

0.8

0.15

307

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

195

1.60

1.69

1.3

—

(3020779) Urea [Moles/volume] in Serum or Plasma

137

1117

1.25

1.67

6.9

7.6

mmol/l

10.0

9.9

0.06

131

1072

(40757373) Influenza virus identified in Isolate

2.81

1.65

1.6

1.5

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

158

1.66

1.63

1.2

—

(36660697) Celiac disease serology panel - Serum

107

851

1.28

1.61

1.1

1.2

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

2.33

1.60

2.3

2.4

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

112

897

1.27

1.60

1.4

1.3

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

135

1106

1.24

1.59

2.0

2.5

ug/l

7.9

7.2

0.13

120

989

(3002179) Metamyelocytes/100 leukocytes in Blood

115

925

1.26

1.58

3.8

4.1

0.7

0.6

0.16

226

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

2.70

1.58

1.0

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

231

1.53

1.58

1.3

1.2

u/ml

57.7

48.3

—

(40768441) Liver Pathology biopsy report

1.83

1.57

1.4

1.3

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

108

864

1.27

1.56

1.9

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

348

1.42

1.55

1.6

1.5

ug/g

262.8

286.1

0.37

200

(40767503) Oxygen content in Capillary blood by calculation

273

1.48

1.55

2.2

2.6

15.5

16.2

0.26

143

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

221

1907

1.19

1.54

1.3

1.2

u/ml

8.2

11.5

0.39

734

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

257

1.49

1.54

4.3

5.4

iu/ml

432.0

223.5

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

349

1.42

1.53

1.5

1.2

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

452

1.36

1.52

2.9

2.5

g/l

3.0

3.1

0.48

358

(3019309) Folate [Moles/volume] in Red Blood Cells

264

2319

1.17

1.49

1.9

1.8

nmol/l

1093.7

1186.3

1.03

210

1734

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

125

1515

0.81

1.49

4.4

4.5

30.9

32.1

0.57

1012

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

1.95

1.49

1.1

1.0

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

139

1.67

1.48

1.3

1.4

pmol/l

188.2

297.5

2.23

111

(3037522) Nuclear Ab [Titer] in Serum

182

1550

1.20

1.48

1.5

1.3

titre

532.5

515.8

0.05

334

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

335

1.42

1.47

2.8

2.3

185.9

191.9

0.16

317

(3021440) Promyelocytes/100 leukocytes in Blood

117

953

1.25

1.46

4.4

0.1

0.25

279

(3000475) Leukocytes [#/volume] in Synovial fluid

302

1.44

1.46

1.4

1.6

e6/l

35601.8

16997.5

0.63

219

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

140

1164

1.22

1.45

2.5

2.2

g/l

0.2

2.12

133

1092

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

115

936

1.25

1.45

4.4

3.8

ng/l

93.3

89.9

0.14

102

824

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

482

1.34

1.45

2.8

2.5

g/l

3.4

3.8

1.80

351

(3014133) Dog dander IgE Ab [Units/volume] in Serum

125

1.69

1.44

1.0

u/ml

6.5

3.2

—

(3051611) Lipemic interference index of Serum or Plasma

125

1.69

1.44

2.4

3.4

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

2.73

1.43

1.0

u/ml

116.2

30.1

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

483

1.34

1.43

2.8

2.5

g/l

7.1

7.4

0.45

367

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

483

1.34

1.43

2.8

2.5

—

(3011985) Renin [Units/volume] in Plasma

149

1.62

1.41

1.6

1.3

mu/l

67.1

44.4

0.26

134

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

2.42

1.39

1.4

1.0

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

322

1.41

1.39

1.6

1.5

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

366

1.38

1.36

2.5

2.1

89.4

90.2

0.07

349

(3005011) Chlamydia sp Ab [Titer] in Serum

2.95

1.36

2.0

1.6

—

(4094501)

341

1.39

1.35

1.0

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

2.14

1.33

1.0

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1.79

1.33

1.4

1.5

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

276

2455

1.15

1.33

1.3

1.2

u/ml

1.3

1.6

0.29

642

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

515

4770

1.12

1.33

4.2

3.7

ng/l

160.3

49.6

0.42

351

3423

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

276

1.42

1.29

1.6

1.9

iu/l

2.9

5.3

2.30

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

405

1.35

1.28

3.7

3.6

mg/l

36.1

71.2

0.57

329

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

743

1.25

1.27

1.9

1.6

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

337

1.38

1.26

1.3

1.4

—

(3012516) Albumin [Mass/volume] in Urine

401

3673

1.13

1.24

3.5

3.3

mg/l

939.9

335.2

0.99

268

2368

(3029937) Albumin [Presence] in Urine by Test strip

348

3163

1.13

1.22

4.8

4.0

estimate

0.0

0.69

129

1083

(3006184) Hemoglobin [Mass/volume] in Capillary blood

263

1.42

1.21

1.5

2.3

g/l

133.7

129.4

0.42

203

(3051651) Icteric interference index of Serum or Plasma

1.80

1.21

1.9

3.7

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

174

1507

1.18

1.19

1.4

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

411

1.33

1.18

3.5

2.7

g/l

1.0

1.3

0.48

364

(3009508) Creatinine [Moles/volume] in Urine

422

3889

1.12

1.17

3.3

3.2

mmol/l

7.2

7.7

1.51

362

3260

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

223

1.44

1.17

1.3

1.5

—

(3013512) EKG study

394

3619

1.12

1.16

3.9

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

430

1.31

1.16

1.8

1.7

mg/l

2.4

4.2

0.73

311

(3034860) Kappa light chains.free [Mass/volume] in Serum

404

1.32

1.15

3.8

3.6

mg/l

42.6

66.2

0.76

327

(3036489) Thrombin time

448

1.31

1.15

2.3

2.0

20.9

21.6

0.54

403

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

1.73

1.15

2.2

1.5

g/l

1.0

0.02

(44813793)

1.81

1.15

1.1

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

1.79

1.11

2.1

2.0

13.4

16.2

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

193

1.46

1.09

1.0

1.1

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

313

1.35

1.07

1.1

1.2

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

1.76

1.07

1.5

1.6

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

178

1.47

1.05

1.3

1.5

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

1.71

1.05

1.9

1.1

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

179

1.46

1.03

1.3

1.5

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

196

1.44

1.02

1.1

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

1.89

1.01

1.0

1.2

iu/ml

151.6

227.5

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

1.66

1.00

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

139

1.52

1.00

1.4

2.2

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

123

1.55

0.99

3.7

2.3

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

261

0.65

0.99

5.9

3.8

mg/l

25.9

27.0

—

170

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.18

0.98

1.0

1.1

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

371

1.30

0.98

1.6

1.9

—

(3029075) Extractable nuclear Ab panel - Serum

1.95

0.97

1.1

1.0

—

(3011412) CD3 cells [#/volume] in Blood

100

1.61

0.97

2.1

e9/l

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

157

1.47

0.96

1.3

1.0

u/ml

1.2

2.3

1.27

(3008152) Bicarbonate [Moles/volume] in Arterial blood

798

1.20

0.96

6.6

7.7

mmol/l

24.9

24.5

0.52

747

(3025159) Blasts/100 leukocytes in Blood

106

900

1.19

0.95

4.4

4.5

0.0

0.5

0.64

240

(3020682) Albumin/Creatinine [Ratio] in Urine

418

3892

1.10

0.95

4.3

4.0

mg/mmol

6.5

8.9

0.90

277

2487

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

172

1520

1.15

0.94

10.1

7.4

—

(3024263) Appearance of Synovial fluid

1.78

0.94

1.4

1.6

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

312

1.32

0.94

1.2

1.1

u/ml

0.7

7.6

—

(3044927) Protein electrophoresis panel - Urine

146

0.55

0.92

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

1.82

0.92

4.3

3.8

—

(21494755) Public health laboratory ask at order entry panel

1010

0.83

0.90

1.3

1.4

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.07

0.89

1.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

142

1244

1.16

0.89

1.6

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

1.91

0.88

2.6

1.9

ug/l

136.0

53.8

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

1.79

0.88

1.1

1.2

—

(3049717) Cytology report of Urine Cyto stain

523

1.23

0.86

2.1

2.7

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

220

1990

1.12

0.86

1.3

iu/ml

22.8

32.6

1.23

635

(3045142) Bone marrow Pathology biopsy report

145

1.45

0.85

1.1

1.3

—

(3036603) Volume of Urine

1.63

0.84

1.5

1.4

2501.3

1865.6

—

(3034426) Prothrombin time (PT)

1.88

0.82

1.0

1.4

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

198

1.37

0.80

1.3

1.5

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

164

1.41

0.80

1.2

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

114

1.50

0.79

1.1

u/ml

5.7

4.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

0.00

0.79

0.0

3.6

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

0.00

0.79

0.0

2.0

—

1.0

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

211

0.66

0.78

1.5

3.4

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

1.63

0.78

1.5

1.6

—

(4281824)

122

0.57

0.78

1.4

1.2

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.51

0.78

2.0

1.5

—

(3044941) Cell count panel - Synovial fluid

208

1.35

0.77

1.6

1.5

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

305

1.29

0.77

1.4

1.2

u/ml

19.1

8.8

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

115

1.48

0.77

2.2

2.4

—

(3025130) Human papilloma virus identified in Specimen

115

1.48

0.77

1.5

1.9

—

(40762365) Oxygen content in Arterial blood by calculation

0.00

0.76

0.0

3.4

—

14.8

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

1.70

0.76

2.2

2.9

u/ml

1037.3

1478.6

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

245

1.31

0.74

1.5

1.3

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

108

1.49

0.73

1.1

1.2

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

150

1.41

0.73

1.5

81.7

62.4

1.92

101

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

525

1.21

0.73

2.1

2.0

ug/l

6.0

1.8

0.75

465

(3018572) Chloride [Moles/volume] in Blood

290

1.28

0.73

6.3

9.0

mmol/l

103.4

105.6

1.30

263

(3039000) Anion gap in Blood

290

1.28

0.73

6.2

9.0

mmol/l

12.3

11.3

0.43

263

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

299

1.28

0.72

1.4

1.2

u/ml

1.8

2.5

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

142

1.41

0.72

1.8

1.7

—

(3003694) ABO and Rh group [Type] in Blood

340

3178

1.09

0.72

1.4

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

241

2615

0.91

0.71

1.8

1.7

pmol/l

66019853.9

28798190.3

0.36

206

2146

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.58

0.71

1.0

1.1

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

1.93

0.70

1.0

1.1

nmol/l

47.8

34.1

—

(40760888) Immunoglobulin light chains.free panel - Serum

301

1.27

0.69

4.3

3.8

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

446

1.22

0.69

2.1

1.9

—

(40761535) Cells panel - Urine sediment

116

1024

1.14

0.69

3.9

3.4

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.85

0.68

1.2

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

222

1.31

0.68

1.5

1.3

u/ml

111.6

127.8

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

118

0.59

0.68

1.3

1.4

nmol/l

1.2

1.4

—

106

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

102

1.48

0.67

1.2

1.3

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

153

1.38

0.67

1.4

1.5

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.79

0.66

1.0

1.1

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

130

0.61

0.63

1.0

1.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

155

1.36

0.63

1.4

1.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

155

1.36

0.63

1.4

1.5

—

(3008898) HLA-B27 [Presence]

397

1.22

0.62

1.1

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

121

1.41

0.62

3.2

3.7

59.9

52.2

—

(3047189) Immunofixation for 24 hour Urine

1.59

0.62

1.2

1.7

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

1.59

0.62

5.9

7.5

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

0.00

0.60

0.0

1.3

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.60

0.0

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

0.00

0.60

0.0

1.3

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

464

1.19

0.59

1.9

2.3

ug/l

910.8

446.9

0.42

441

(3019150) Specific gravity of Urine by Refractometry

274

2562

1.09

0.59

5.1

4.0

kg/l

1.0

1.56

377

(3037756) Immunofixation for Serum or Plasma

282

1.25

0.58

1.5

1.6

—

(21494434) Karyotype in Bone marrow

123

1.39

0.58

1.0

1.2

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

158

1441

1.11

0.57

1.6

1.8

1.5

0.11

128

1246

(3015183) Erythrocyte sedimentation rate

1.46

0.56

1.1

1.2

—

(3004809) Band form neutrophils/100 leukocytes in Blood

194

1.29

0.56

3.2

3.7

0.8

1.5

0.89

160

(4015189)

1.62

0.55

1.0

2.6

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

1.48

0.53

2.3

2.0

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

160

1.32

0.53

1.8

1.6

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

152

1.32

0.52

1.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

152

1.32

0.52

1.5

—

(3017569) Oxygen content in Arterial blood

1.41

0.51

1.3

3.0

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

426

1.18

0.50

2.2

2.6

u/ml

0.3

0.42

238

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

1.39

0.50

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

1.39

0.50

1.0

—

(3028707) Methadone [Presence] in Urine by Screen method

153

1.31

0.50

1.3

2.8

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

153

1.31

0.50

1.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

1.50

0.49

1.7

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

1.50

0.49

1.7

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

1.50

0.49

1.7

1.9

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

1.50

0.49

1.7

1.9

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

353

1.20

0.49

2.0

1.8

—

(3038515) Glucose [Moles/volume] in Venous blood

268

0.78

0.49

5.0

3.3

mmol/l

8.2

7.5

0.55

262

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

486

4670

1.06

0.49

5.0

4.8

ug/l

2.4

2.7

0.45

431

4183

(3043410) Blood group antigens tested for on Red Blood Cells

1.56

0.49

1.9

1.4

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

110

1.37

0.49

1.5

1.4

20.7

30.3

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

667

0.86

0.48

1.4

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

1.52

0.48

1.1

1.2

—

17.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

392

3744

1.06

0.48

4.1

4.2

23.2

21.4

1.42

182

1788

(3036071) Salmonella sp Ab [Titer] in Serum

1.49

0.47

1.0

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

318

1.20

0.47

1.7

2.4

ug/min

114.4

93.8

0.18

191

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

263

1.22

0.47

1.2

2.0

nmol/l

0.9

0.8

0.07

220

(3000330) Specific gravity of Urine by Test strip

617

1.14

0.47

4.2

3.6

—

(3035320) C reactive protein [Mass/volume] in Body fluid

1.42

0.47

3.0

2.2

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

468

4500

1.06

0.46

4.7

3.9

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

310

1.20

0.46

1.6

1.7

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

1.43

0.45

2.5

2.6

32.2

42.2

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

525

1.15

0.45

5.2

6.3

1.8

1.6

0.54

493

(3022621) pH of Urine by Test strip

782

1.12

0.44

3.0

2.9

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1.37

0.44

1.1

1.5

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

1.37

0.43

1.0

1.1

—

43.4

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

285

0.80

0.43

1.5

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

140

0.71

0.43

1.0

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.66

0.42

1.0

1.1

—

(3045788) Cell count panel - Pleural fluid

122

1.31

0.42

1.9

1.4

—

(40768806) Pleura Pathology biopsy report

140

1.29

0.42

1.6

1.5

—

(1761868) Lipid panel - Serum or Plasma

405

4214

0.95

0.42

2.9

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

1.36

0.41

1.0

1.1

—

61.9

—

(44806071)

0.00

0.41

0.0

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

0.00

0.41

0.0

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

0.00

0.41

0.0

1.3

—

47.5

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

0.00

0.41

0.0

2.8

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

0.7

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

0.00

0.41

0.0

2.8

—

(3009015) Lactate [Moles/volume] in Synovial fluid

0.00

0.41

0.0

1.4

—

6.2

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.00

0.41

0.0

2.6

—

(3000012) Reticulocyte production index

1.34

0.40

1.3

1.9

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

0.00

0.40

0.0

1.4

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.43

0.39

1.0

1.3

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

1.41

0.39

2.1

1.6

u/field

0.9

5.3

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

0.00

0.39

0.0

1.0

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

524

1.13

0.38

5.2

6.3

0.9

0.12

493

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

1.33

0.37

1.2

1.3

—

69.0

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

996

0.91

0.37

1.6

1.8

—

(3020891) Body temperature

506

1.13

0.37

4.3

4.6

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

1.35

0.37

1.0

1.1

pmol/l

211.2

294.0

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

1.27

0.36

1.3

—

(3044242) Glucose [Moles/volume] in Arterial blood

1.27

0.36

1.1

3.0

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

226

1.20

0.36

1.8

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

0.66

0.35

1.0

1.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

273

1.18

0.35

1.5

1.4

e6/l

32.1

41.8

0.13

211

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

273

1.18

0.35

1.5

e6/l

21461.0

836.9

0.53

220

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

126

0.71

0.35

1.0

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

1.33

0.33

1.0

1.1

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

265

1.17

0.33

2.0

1.9

pmol/l

204.5

217.0

0.23

249

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

100

1.30

0.33

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

127

1.26

0.33

1.9

1.6

—

(4306422)

173

1.22

0.33

1.3

1.2

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

369

1.14

0.33

1.5

1.6

iu/ml

0.5

19.8

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

1.28

0.32

1.2

1.3

—

(3019225) pH of Specimen

112

1203

0.93

0.32

4.8

4.5

—

(3023183) Ammonium ion [Moles/volume] in Plasma

286

1.16

0.31

2.7

3.2

umol/l

30.2

34.6

0.66

237

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

282

2708

1.05

0.31

3.0

ug/l

0.8

0.7

0.57

188

1782

(3027944) Amphetamines [Presence] in Urine

344

1.14

0.29

1.3

1.9

—

(3000764) Benzodiazepines [Presence] in Urine

344

1.14

0.29

1.3

2.0

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

269

1.16

0.29

1.5

2.2

—

(4024509)

107

0.75

0.29

1.1

1.5

—

(3027008) Opiates [Presence] in Urine

345

1.13

0.28

1.3

2.0

—

(3039443) Prostate specific Ag panel - Serum or Plasma

270

0.85

0.28

1.7

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

729

1.09

0.28

1.1

1.2

iu/ml

73.9

139.7

1.81

287

(3028300) Cannabinoids [Presence] in Urine

346

1.13

0.28

1.3

1.9

—

(3017732) Neutrophils [#/volume] in Blood

790

1.08

0.26

3.3

3.2

e9/l

4.0

4.1

0.07

611

(3027923) C peptide [Moles/volume] in Serum or Plasma

1.20

0.26

1.0

1.3

nmol/l

1.5

1.1

—

(3032773) Endomysium IgG Ab [Titer] in Serum

1.27

0.26

1.0

1.1

titre

—

(3004616) Nuclear Ab [Presence] in Serum

141

1.21

0.26

1.4

1.2

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

0.68

0.26

43.0

19.6

nmol/l

1570.0

1492.6

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

1.25

0.25

1.0

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

123

1.22

0.25

1.9

1.6

—

(3011288) Drugs identified in Urine by Screen method

226

1.15

0.25

1.4

3.0

—

(3044290) Cell count panel - Cerebral spinal fluid

245

1.15

0.24

1.5

—

(3025577) Chromium [Mass/volume] in Blood

0.74

0.24

2.0

2.1

ug/l

1.0

1.9

—

(3017704) Immunofixation for Urine

0.73

0.24

2.3

1.6

—

(3026470) Cobalt [Mass/volume] in Blood

0.73

0.24

2.0

ug/l

2.3

3.0

—

(3023199) Leukocytes [#/volume] in Pleural fluid

152

1.19

0.23

1.7

1.4

e6/l

625.4

1617.6

3.07

106

(3035880) pH of Pleural fluid

1.27

0.22

1.1

1.3

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

267

1.13

0.21

1.3

1.4

—

(3000093) Morphology [Interpretation] in Blood Narrative

107

1.22

0.21

1.0

1.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

107

1.22

0.21

1.0

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

0.00

0.21

0.0

1.3

—

(3017509) Phencyclidine [Presence] in Urine

0.00

0.21

0.0

1.2

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.00

0.21

0.0

1.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

0.00

0.21

0.0

1.0

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.2

—

(3001729) Color of Synovial fluid

0.00

0.21

0.0

1.3

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.2

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.0

—

173.2

—

(44806420)

1.16

0.21

2.8

2.4

—

(3050129) First trimester maternal screen panel - Serum or Plasma

177

0.85

0.21

1.4

1.5

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.21

0.0

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.0

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.00

0.21

0.0

1.4

—

(3009343) pH of Capillary blood

810

0.93

0.20

4.1

3.6

7.4

—

112

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

0.00

0.20

0.0

1.3

—

95.3

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.00

0.20

0.0

1.3

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

136

1.18

0.20

1.8

1.4

e6/l

44158.6

73498.7

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

819

0.94

0.20

4.2

3.6

kpa

5.1

0.05

766

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

115

0.78

0.20

1.1

1.0

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

197

0.86

0.19

1.2

1.1

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

582

0.93

0.19

5.4

3.7

51.6

49.0

0.33

574

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

298

1.11

0.19

1.7

—

(3003740) Influenza virus B Ag [Presence] in Specimen

184

1.14

0.19

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

184

1.14

0.19

1.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

1.15

0.19

1.8

2.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

1.15

0.19

1.8

2.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

1.13

0.18

1.8

2.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

128

1.17

0.18

4.9

2.8

—

(40768793) Breast Pathology biopsy report

248

0.89

0.18

1.4

1.3

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

227

0.88

0.18

1.1

1.3

—

(44790047)

138

1.16

0.17

1.6

1.5

—

(44790049)

138

1.16

0.17

1.6

1.5

—

(44806118)

138

1.16

0.17

1.6

1.5

—

(44790048)

138

1.16

0.17

1.6

1.5

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

184

0.87

0.17

1.3

1.2

u/ml

2.0

4.5

—

(3016879) Cocaine [Presence] in Urine

320

1.10

0.17

1.3

2.0

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

1.22

0.17

1.4

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

1.22

0.17

1.4

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

1.22

0.17

1.4

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

330

0.91

0.17

6.6

4.7

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

186

1.13

0.17

1.8

1.5

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

534

1.07

0.16

1.1

1.0

—

(3022313) Gas panel - Capillary blood

587

0.93

0.16

4.8

3.7

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

350

1.09

0.16

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

1.14

0.16

1.1

1.6

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

162

0.86

0.16

3.4

2.6

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

1.21

0.15

1.4

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

1.21

0.15

1.4

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

1.21

0.15

1.4

1.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

1.15

0.15

1.2

1.3

ug/l

3.1

2.5

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

265

1.10

0.14

2.5

3.1

nmol/l

0.9

0.8

0.07

208

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

0.79

0.14

1.0

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

0.78

0.14

1.3

u/l

13.3

13.8

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

382

1.08

0.14

1.9

1.8

—

(3025941) Bacteria identified in Stool by Culture

627

1.06

0.13

1.3

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

159

0.88

0.13

1.1

1.2

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

345

0.93

0.13

3.4

2.8

mmol/l

24.8

0.03

302

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

306

1.08

0.13

1.3

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

404

1.07

0.12

1.5

1.6

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

1.18

0.12

1.0

1.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

768

1.04

0.11

1.5

1.6

—

(4146454)

126

0.87

0.11

3.2

2.6

—

(3023410) Appearance of Cerebral spinal fluid

125

1.12

0.10

1.9

1.6

—

(3037556) Urate [Mass/volume] in Serum or Plasma

1.14

0.10

1.0

1.3

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

132

1286

1.03

0.10

3.6

4.3

ug/l

67.2

23.0

0.33

106

1060

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

193

1.09

0.10

1.6

—

(40768446) Kidney Pathology biopsy report

1.11

0.09

1.8

1.6

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

176

0.91

0.09

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

116

1.12

0.09

1.3

1.5

nmol/l

0.3

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

233

1.07

0.09

1.1

1.2

u/ml

189.5

275.7

1.01

140

(3041096) Erythrocytes [Presence] in Urine by Automated

322

3177

1.02

0.09

3.7

3.4

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

134

0.89

0.08

1.3

1.6

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

1.03

0.08

2.5

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

1.03

0.08

2.5

1.4

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

0.82

0.08

1.0

1.3

ug/l

3.4

5.8

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

0.81

0.08

6.0

3.2

—

(4034850)

379

0.95

0.08

15.9

10.9

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

117

1.11

0.08

1.6

1.7

—

(3006653) Thiamine [Moles/volume] in Blood

1.08

0.08

2.0

1.3

nmol/l

128.9

145.0

—

(40757494) Bilirubin.total [Moles/volume] in Blood

1.04

0.08

2.4

1.9

—

48.3

—

(3021901) Oxygen saturation in Capillary blood

246

1.06

0.06

2.3

2.6

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

131

0.92

0.05

1.2

1.5

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

455

1.03

0.05

1.9

1.8

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

110

1.09

0.05

1.7

1.6

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

248

1.05

0.05

1.1

1.2

—

(3037121) Protein [Mass/volume] in Urine

454

0.97

0.04

2.0

3.5

g/l

0.2

0.3

0.30

190

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

776

0.98

0.04

3.6

3.5

mmol/l

1.6

1.8

0.22

575

(3008757) Leukocyte morphology finding [Identifier] in Blood

140

1.07

0.04

2.7

4.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

281

0.96

0.04

1.5

1.4

—

(3005570) Glucose [Moles/volume] in Urine

131

1.07

0.03

1.4

2.2

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

230

1.04

0.03

1.8

2.3

u/l

3616.4

3376.4

—

(3001019) Free T4 and TSH panel - Serum or Plasma

508

1.02

0.03

1.4

1.7

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

128

0.94

0.02

1.0

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

123

1.06

0.01

1.5

1.8

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

483

1.01

0.01

3.3

3.4

u/ml

12632.4

3087.4

0.34

408

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

104

1.06

0.01

1.2

—

(3012441) Differential panel - Pleural fluid

136

0.96

0.00

1.8

1.4

—

(3045424) Erythrocytes [Presence] in Urine

206

0.97

0.00

1.4

1.3

—

(40768800) Prostate Pathology biopsy report

286

0.98

0.00

1.1

1.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

114

0.96

0.00

1.1

1.2

—

(3020876) Protein [Mass/time] in 24 hour Urine

116

1.03

0.00

1.3

2.1

—

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

116

1.03

0.00

1.6

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

116

1.03

0.00

1.6

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

116

1.03

0.00

1.6

1.7

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

136

1.03

0.00

1.4

1.8

—

(4268621)

118

1.02

0.00

2.1

2.3

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

494

0.99

0.00

4.4

4.0

mmol/l

24.6

24.9

0.27

465

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

152

0.99

0.00

1.3

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

152

0.99

0.00

1.3

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

152

0.99

0.00

1.3

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

152

0.99

0.00

1.3

1.4

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

292

0.99

0.00

1.5

1.3

miu/ml

241.6

227.5

0.07

131

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

183

0.98

0.00

1.3

1.2

u/ml

2.1

6.4

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

493

0.99

0.00

2.2

1.9

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

165

1.03

0.00

1.2

1.5

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

125

0.96

0.00

1.2

1.4

—

(3005033) Fetal Nuchal fold Thickness US

125

0.96

0.00

1.2

1.4

—

(3020393) Adenovirus Ag [Presence] in Stool

0.00

0.0

1.0

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

0.00

0.0

1.1

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.0

1.3

—

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

0.0

1.0

—

38.9

—

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

0.0

1.0

—

21.3

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

1.01

0.00

2.3

1.4

—

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

0.0

1.0

—

7.5

—

(3025315) Body weight

0.00

0.0

3.5

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

1.01

0.00

2.3

1.4

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

0.87

0.00

1.2

6.5

—

69.3

—

(3016038) Potassium [Moles/volume] in Urine

0.98

0.00

2.3

1.1

mmol/l

40.5

34.5

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.95

0.00

1.5

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

1.00

0.00

1.0

1.2

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

0.00

0.0

1.0

—

(3013466) aPTT in Blood by Coagulation assay

0.00

0.0

1.0

—

34.3

—

(3011048) Pyruvate [Moles/volume] in Blood

0.00

0.0

1.1

—

85.6

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.0

1.2

—

7.5

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

0.0

1.2

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3022475) Manganese [Moles/volume] in Blood

0.00

0.0

1.6

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

0.00

0.0

1.0

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

0.00

0.0

2.4

—

168.2

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.0

1.5

—

2.2

—

(3007463) Buprenorphine [Presence] in Urine

0.00

0.0

2.7

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.0

1.8

—

1.5

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

0.93

0.00

1.0

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

0.92

0.00

1.5

—

73.5

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.7

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.0

—

(3006270) Folate [Moles/volume] in Blood

0.92

0.00

1.1

nmol/l

450.3

380.5

—

(3013862) HLA-DP [Type]

0.00

0.0

1.0

—

(3042517) Benzodiazepines panel - Urine

0.00

0.0

1.1

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3023511) Choriogonadotropin [Units/volume] in Urine

130

1.00

0.00

1.1

1.3

—

(40760410) HLA-B [Type] by High resolution

0.00

0.0

1.0

—

(4027681)

0.95

0.00

1.4

1.2

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.00

0.0

1.6

—

403.1

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.0

1.0

—

(40760409) HLA-A [Type] by High resolution

0.00

0.0

1.0

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.0

1.2

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

0.00

0.0

1.8

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.2

—

(3004451) EKG impression Narrative

0.95

0.00

1.3

1.2

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

4.2

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

0.00

0.0

1.0

—

(3045716) Anion gap in Serum or Plasma

0.90

0.00

1.7

2.0

mmol/l

9.3

9.7

—

(3036525) Urea [Moles/time] in 24 hour Urine

0.00

0.0

4.9

—

(40763590) HLA-DQ beta [Type]

0.00

0.0

1.0

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.0

1.3

—

15.2

—

(3013762) Body weight Measured

0.00

0.0

1.4

—

Mortality – FinRegistry

↥

Association

Association between endpoint CD2_BENIGN_EAR_NASAL_SINUS and mortality.

Females

Parameter	HR [95% CI]	p-value
CD2_BENIGN_EAR_NASAL_SINUS	1.289 [1.13, 1.47]	< 0.001
Birth year	0.995 [0.99, 1.0]	0.221

During the follow-up period (1.1.1998 — 31.12.2019), 531 out of 3276 females with CD2_BENIGN_EAR_NASAL_SINUS died.

Males

Parameter	HR [95% CI]	p-value
CD2_BENIGN_EAR_NASAL_SINUS	1.197 [0.99, 1.44]	0.058
Birth year	0.989 [0.94, 1.04]	0.691

During the follow-up period (1.1.1998 — 31.12.2019), 689 out of 3623 males with CD2_BENIGN_EAR_NASAL_SINUS died.

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_EAR_NASAL_SINUS.

N-year risk	Females	Males
1	0.15%	0.216%
5	0.85%	1.352%
10	2.003%	3.63%
15	3.69%	6.902%
20	6.21%	11.55%

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_EAR_NASAL_SINUS – Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints